Court accepts Hugel’s request to suspend revocation of product licenses The achievement highlights the pharmaceutical company's risk management capabilities
Translated by Ryu Ho-joung 공개 2021-12-23 08:18:46
이 기사는 2021년 12월 21일 06:54 더벨 유료페이지에 표출된 기사입니다.
South Korean botox maker Hugel has obtained a court order allowing it to continue to sell its botulinum toxin products regulated by the country’s Ministry of Food and Drug Safety for now, clearing a hurdle ahead of its planned acquisition by a GS Group-led consortium.On Friday, the Seoul Administrative Court accepted the company’s request to suspend the MFDS’ decision. In November, the authority said it would revoke licenses of four botox products made by Hugel for failing to get necessary approval to supply them domestically, and ordered the company to recall and dispose of them.
Hugel immediately released a statement saying that transactions regulated by the MFDS were made to export the products, which is not subject to domestic regulations.
With Friday’s court decision, the license revocation, which took effect December 13, will be nullified until the main case filed by Hugel against the MFDS is resolved.
Hugel is set to change hands after a consortium led by South Korean conglomerate GS Group signed a deal to buy a controlling stake in the pharmaceutical company from private equity firm Bain Capital this summer.
Earlier this month, the deal received a nod from the country’s trade ministry, which concluded that the acquisition poses no concern of technology leaks. Many expect the deal to close before the deadline of January 12, 2022.
Hugel’s dealings with the MFDS highlight its strong risk management capabilities, industry watchers said. Hugel also obtained licenses for its botox products from Chinese health authorities last year to become the first such company in South Korea. This was an achievement by the company which sought to expand into global markets amid cutthroat competition among domestic botox makers.
“We are not shaken by the acquisition process and other issues and continue to focus on increasing our competitiveness,” an official at Hugel said. “We will also increase shareholder value by retiring treasury shares and paying dividends.” (Reporting by Eun-su Choi)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재 및 재배포 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- '플랫폼 진화' SAMG엔터, 올해 1000억 매출 정조준
- 신화콘텍, 하락장서 자사주 활용법 '눈길'
- THQ 새 주인 '휴림로봇', FI 엑시트 구조까지 마련
- IPO 앞둔 유니슨HKR, 복층 지배구조 '단순화'
- [현장 인 스토리]'광트랜시버 명가' 라이트론, 연구소 투자 '잰걸음'
- [헤지펀드 판매사 지형도 분석]한투증권, 브레인 메인창구 등극
- 네오스인베, 미국 시장에 옵션인컴형 ETF 내놓는다
- 한투운용, 700억 규모 사모 ELF 2종 결성
- 모루운용, 장인PE 2호 만기 연장…명진홀딩스 부진 탓
- 강원랜드, OCIO에 돈 더 푼다…'규모의 경제' 목표